BPTH - Prakiraan volume dodolan Bio-Path Holdings Inc.

Logo grafis Bio-Path Holdings, Inc. (BPTH)

A stable geopolitical backdrop and the humanitarian status of biomedicine minimize external risks for Bio-Path Holdings (BPTH). Internal growth relies on the expansion of the DNAbilize platform and the broadening of clinical trials in oncohematology. Revenue expectations for the company depend on biological breakthroughs in leukemia treatment, with the 0.00 mark serving as a key metric for the current market valuation.

BPTH - Dodolan mangsa ngarep perusahaan Bio-Path Holdings ing rentang 04.07.2022 - 01.03.2025

BPTH (Bio-Path Holdings Inc.): rincian analitis lan laporan miturut indikator

- kuotasi lan prakiraan analis:
Rega saham Bio-Path Holdings|BPTH - Prakiraan gabungan firma investasi
- statistik kapitalisasi pasar:
Kapitalisasi pasar Bio-Path Holdings Inc.|BPTH - Nilai Total Perusahaan
- informasi kapitalisasi buku:
Nilai Buku saben Saham Bio-Path Holdings|BPTH - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku biopathholdings.com|BPTH - Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Bio-Path Holdings|BPTH - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Bio-Path|BPTH - Gunggung tanggungan utang perusahaan|Utang-utang marang kapitalisasi buku Bio-Path Holdings Inc.|BPTH - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Bio-Path Holdings|Rasio cepet biopathholdings.com
- statistik bathi lan rasio pasar:
BPTH - Bathi pungkasan|Bathi mangsa ngarep Bio-Path Holdings|BPTH - Nilai perusahaan marang bathi resik|Pangali Forward P/E Bio-Path Holdings, Inc.|BPTH - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Bio-Path Holdings Inc.|BPTH - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Bio-Path Holdings|BPTH - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan biopathholdings.com|BPTH - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Bio-Path Holdings
- data pendapatan lan penerimaan dodolan:
BPTH - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan Bio-Path Holdings|BPTH - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S Bio-Path Holdings Inc.
Pambiji fundamental perusahaan:Bio-Path Holdings
Sampel barang Bio-Path

This indicator assesses the issuer's projected revenue by analyzing cash flow dynamics and market expectations. A declining line signals a degradation of the business model, while growth confirms scaling potential. For Bio-Path Holdings (BPTH), the company's future sales figures depend directly on the success of liposomal drug trials against leukemias. This chart allows for an assessment of whether the market currently prices in the commercial success of these developments. A stable trend will serve as a signal for long-term holding of the asset.

Analisis perusahaan pesaing

Prakiraan volume dodolan TGTX|arcellx.com - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan IRON (Disc Medicine)|Syndax Pharmaceuticals Inc - Prakiraan pendapatan perusahaan|Kura Oncology Corp - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan ADC Pharma ADCT|foghorntx.com (FHTX) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan vorbio.com (VOR)|Volume dodolan mangsa ngarep perusahaan NKTX|COEP - Prakiraan dodolan perusahaan|Prakiraan pendapatan perusahaan Actinium Pharmaceuticals Inc (ATNM)|ESLA: Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan CASI (CASI Pharmaceuticals, Inc.)|Prakiraan volume dodolan Marker Therapeutics Inc MRKR|INAB: Volume dodolan mangsa ngarep perusahaan|Eterna Therapeutics - Prakiraan volume pendapatan perusahaan|GTBP: Prakiraan volume dodolan|Aptose Biosciences - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan MEIP|VINC: Pendapatan mangsa ngarep perusahaan